EV/EBITDA
-7.40
-0.19-2.64%
Thu, 13 Mar 2025 23:56:58 GMT
Summary
- As of March 14, 2025, CADL EV/EBITDA is -7.40, with a fall of -0.19 (-2.64%) during the most recent trading day.
- CADL EV/EBITDA is now -2155.56% below its all-time high of 0.36.
Performance
CADL EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CADL EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | -2.6% | +2.6% | +2.6% |
1 m1 month | +9.4% | -9.4% | -9.3% |
3 m3 months | -65.9% | +66.0% | +21.1% |
6 m6 months | -52.9% | +60.7% | +14.7% |
ytdytd | +6.7% | -6.7% | -6.7% |
1 y1 year | - | +780.7% | +418.5% |
5 y5 years | - | - | - |
CADL EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -3.1% | -11.14 | +33.6% | |
3 m | 3-month | -4.46 | -65.9% | -11.14 | +33.6% |
6 m | 6-month | -2.62 | -182.4% | -11.14 | +33.6% |
1 y | 1-year | -1.33 | -456.4% | -12.79 | +42.1% |
3 y | 3-year | 0.36 | -2155.6% | -12.79 | +42.1% |
5 y | 5-year | 0.36 | -2155.6% | -16.88 | +56.2% |
alltime | all time | 0.36 | -2155.6% | -16.88 | +56.2% |
Candel Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -7.40(-6.7%) |
2024 | -7.93(+844.0%) |
Date | Value |
---|---|
2023 | -0.84(+546.2%) |
2022 | -0.13(-97.8%) |
2021 | -5.83 |
FAQ
- What is Candel Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Candel Therapeutics?
- What is CADL EV/EBITDA year-to-date change?
What is Candel Therapeutics EV/EBITDA?
The current EV/EBITDA of CADL is -7.40
What is the all time high EV/EBITDA for Candel Therapeutics?
Candel Therapeutics all-time high EV/EBITDA is 0.36
What is CADL EV/EBITDA year-to-date change?
Candel Therapeutics EV/EBITDA has changed by +0.53 (+6.68%) since the beginning of the year